Skip to Content
Merck
CN

P4922

Phosphate-Citrate Buffer with Sodium Perborate

capsule

Synonym(s):

PCR Buffer with Sodium Perborate

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.25
UNSPSC Code:
12161700
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


form

capsule

Quality Level

pH

4.5-5.5

solubility

water: soluble

Application

Phosphate-citrate buffer with sodium perborate has been used as a substrate buffer in enzyme linked immunosorbent assay (ELISA).

Preparation Note

Empty the contents of one capsule in 100 mL of deionized water and dissolve. The contents of one capsule yields 0.05 M phosphate-citrate buffer, containing 0.03% sodium perborate as a substitute for H2O2, pH 5.0 at 25 °C.


pictograms

Health hazard

signalword

Danger

hcodes

Hazard Classifications

Repr. 1B

Storage Class

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Characterization of a mouse model of allergy to a major occupational latex glove allergen Hev b 5
Hardy CL, et al.
American Journal of Respiratory and Critical Care Medicine, 167(10), 1393-1399 (2003)
Ted M Ross et al.
Vaccine, 37(17), 2369-2376 (2019-03-25)
Since the first identification of the H5N1 Goose/Guangdong lineage in 1996, this highly pathogenic avian influenza virus has spread worldwide, becoming endemic in domestic poultry. Sporadic transmission to humans has raised concerns of a potential pandemic and underscores the need
Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy
Bekesi G, et al.
British Journal of Obstetrics and Gynaecology, 108(5), 474-481 (2001)



Global Trade Item Number

SKUGTIN
P4922-100CAP04061835547609
P4922-50CAP04061834375425